Rigontec's Series A - II Round

Rigontec raised a round of funding on March 24, 2015.

Rigontec is a biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases.…

Articles about Rigontec's Series A - II Round: